People at risk for anaphylaxis can begin ordering AUVI-Q® epinephrine auto-injectors today through Kaléo’s direct delivery service. 

According to the company, it is also launching its AUVI-Q AffordAbility™ program:

• People with commercial insurance will have an out-of-pocket cost of $0 - even if their insurance company will not cover AUVI-Q. That also applies to those with high-deductible plans.
• For patients who do not have government or commercial insurance, and have a household income of less than $100,000, AUVI-Q will be available free of charge.
• The cash price for AUVI-Q is $360 and will be available to those patients without government or commercial insurance.
• The company is still working on government pricing, such as for those covered by Medicaid or Medicare.

The company said their direct-delivery service is the preferred method of obtaining AUVI-Q® for several reasons:

• Epinephrine auto-injectors ordered through their service will have the longest possible expiration dates. For example, auto injectors shipping February 10, 2017 will have April, 2018 expiration dates on them.
• Ordering through the direct delivery service will guarantee an out-of-pocket cost of $0 and the process will be seamless.
• It may take a while for AUVI-Q to reach retail pharmacy shelves, so right now, the direct-delivery service is the fastest option.

To order from the service, patients should give their doctor a copy of the enrollment form. After the order is received, the direct-delivery service will call to verify insurance details and arrange shipping.